Cisco
CSCO
NVIDIA
NVDA
Broadcom
AVGO
Apple
AAPL
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
CRMD CorMedix
- 6.440
- -0.270-4.02%
Trading Mar 28 10:06 ET
419.77MMarket Cap-21.47P/E (TTM)
6.710High6.310Low590.17KVolume6.620Open6.710Pre Close3.84MTurnover0.92%Turnover RatioLossP/E (Static)65.18MShares13.85052wk High4.96P/B415.44MFloat Cap3.61052wk Low--Dividend TTM64.51MShs Float52.000Historical High--Div YieldTTM5.96%Amplitude0.729Historical Low6.509Avg Price1Lot Size
CorMedix News
Truist Financial Initiates CorMedix(CRMD.US) With Buy Rating
Institutions Along With Individual Investors Who Hold Considerable Shares InCorMedix Inc. (NASDAQ:CRMD) Come Under Pressure; Lose 35% of Holdings Value
CorMedix (NASDAQ:CRMD) Shareholders Are Still up 127% Over 5 Years Despite Pulling Back 35% in the Past Week
Analysts Conflicted on These Healthcare Names: Beta Bionics, Inc. (BBNX), Cormedix (CRMD) and Bolt Biotherapeutics (BOLT)
RBC Capital Reiterates Outperform on Cormedix, Maintains $12 Price Target
Cormedix Inc (CRMD) Q4 2024 Earnings Call Highlights: A Profitable Quarter Amidst Strategic ...
JMP Securities Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $19
Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $12
Rodman & Renshaw Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $20
CorMedix Inc. Achieves Profitability With DefenCath Launch
Cormedix: Buy Rating Affirmed Amid Growth Potential and Strategic LDO Partnerships
Needham Cuts CorMedix's Price Target to $12 From $18, Keeps Buy Rating
Cormedix: Positive Outlook With Strategic Advancements and Strong Financial Performance
12 Health Care Stocks Moving In Tuesday's Intraday Session
CorMedix Shares Plunge After 1H Guidance Missed Expectations
CorMedix Down Over 31%, on Pace for Largest Percent Decrease Since August 2022 -- Data Talk
Earnings Call Summary | CorMedix(CRMD.US) Q4 2024 Earnings Conference
CorMedix Shares Tumble After Order Delay
Express News | D. Boral Capital Maintains Buy on Cormedix, Maintains $15 Price Target
Cormedix Analyst Ratings
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.